|
Number of DRPs
|
|
One
|
64 (21.3)
|
|
Two
|
121 (40.3)
|
|
Three
|
55 (18.3)
|
|
Four
|
6 (2.0)
|
|
Category of DRP and its causes
|
|
Need for additional drug therapy
|
145 (29.4)
|
|
Medical condition requires the initiation of drug therapy
|
4 (2.8)
|
|
Preventive drug therapy required to reduce the risk of developing a new condition
|
124 (85.5)
|
|
Medical condition requires additional pharmacotherapy to attain synergistic or additive effects
|
12 (8.3)
|
|
Required preventive drug therapy to reduce the risk of developing a new condition & a medical condition requires additional pharmacotherapy to attain synergistic or additive effects
|
5 (3.4)
|
|
Ineffective drug
|
138 (27.9)
|
|
The drug not the most effective for the medical problem
|
114 (82.6)
|
|
The drug product is not effective for the indication being treated
|
24 (17.4)
|
|
Dosage too low
|
78 (15.8)
|
|
The dose is too low to produce the desired response
|
76 (97.4)
|
|
Drug interaction reduces the amount of active drug available
|
2 (2.6)
|
|
Noncompliance
|
60 (12.2)
|
|
The patient prefers not to take the medication
|
6 (10.0)
|
|
The patient forgets to take the medication
|
27 (45.0)
|
|
The drug product too expensive for the patient
|
3 (5.0)
|
|
The patient prefers not to take the medication & the patient forgets to take the medication
|
17 (28.3)
|
|
The patient forgets to take the medication & the drug product too expensive for the patient
|
5 (8.3)
|
|
The patient prefers not to take the medication, the drug product too expensive for the patient & the patient forgets to take the medication
|
2 (3.3)
|
|
Unnecessary drug therapy
|
51 (10.3)
|
|
No valid medical indication for the drug
|
45 (88.2)
|
|
Multiple drug products are being used for a condition that requires single drug therapy
|
4 (7.8)
|
|
No valid medical indication for the drug & multiple drug products are being used for a condition that requires single drug therapy
|
2 (3.9)
|
|
Adverse drug reaction
|
13 (2.6)
|
|
The drug product causes an undesirable reaction that is not dose-related
|
7 (53.9)
|
|
The drug product contraindicated due to risk factors
|
6 (46.2)
|
|
Dosage too high
|
9 (1.8)
|
|
Dose too high
|
7 (77.8)
|
|
A drug interaction occurs resulting in a toxic reaction to the drug product
|
2 (22.2)
|
